EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs

EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs
EMA
23 Aug 2017
Share Share
EMA recommends suspension of medicines - Micro Therapeutic Research Labs

EMA recommends suspension of medicines - Micro Therapeutic Research Labs
EMA
12 Jul 2017
Share Share
EMA says CRO monitoring activity not location based

EMA says CRO monitoring activity not location based
G. MacDonald IN PHARMATECHNOLOGIST
30 Mar 2017
Share Share
EMA recommends suspension of medicines due to unreliable studies from Micro T.

EMA recommends suspension of medicines due to unreliable studies from Micro T.
EMA
27 Mar 2017
Share Share
EMA looks to suspend 331 drugs ‘misrepresentation of study data’ at Indian CRO

EMA looks to suspend 331 drugs ‘misrepresentation of study data’ at Indian CRO
D. Stanton IN PHARMATECHNOLOGIST
27 Mar 2017
Share Share
EMA Calls to Suspend More Than 300 Drugs due to Unreliable Studies - Indian CRO

EMA Calls to Suspend More Than 300 Drugs due to Unreliable Studies - Indian CRO
Zachary Brennan RAPS
25 Mar 2017
Share Share
Start of a review concerning the conduct of studies at Micro Therapeutic

Start of a review concerning the conduct of studies at Micro Therapeutic
EMA
26 Jan 2017
Share Share
EU regulators uncover data-integrity concerns at Indian CRO

EU regulators uncover data-integrity concerns at Indian CRO
EMA
16 Dec 2016
Share Share

All Pharma News All Pharma News

TOP 10 NEWS OF THE DAY
TOP 10 NEWS
OF THE DAY
NEWS LIBRARY
NEWS
LIBRARY
COMPLIANCE ALERTS
COMPLIANCE
ALERTS
RECENT APPROVALS
RECENT
APPROVALS
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty